胎盘植入谱系的患病率及主要结局:一项系统综述与Meta分析
该研究检索1982—2018年文献,纳入29项研究(22项回顾性、7项前瞻性),共7001例胎盘植入谱系病例、5,719,992次分娩。总体合并患病率为0.17%(95%CI 0.14-0.19),围产期子宫切除合并发生率为52.2%(95%CI 38.3-66.4),需输血出血为46.9%(95%CI 34-59.9),孕产妇死亡为0.05%(95%CI 0.06-0.69),研究间异质性大。
要点
- 胎盘植入谱系总体合并患病率为0.17%(95%CI 0.14-0.19)。
- 围产期子宫切除合并发生率为52.2%(95%CI 38.3-66.4;I²=99.8%)。
- 需输血出血合并发生率为46.9%(95%CI 34-59.9;I²=98.8%)。
核心结论
- Meta分析显示,不同研究间胎盘植入谱系患病率及植入性胎盘不同分级存在较大差异,突出说明需要统一用于描述分娩时胎盘植入谱系及报告这一日益常见产科并发症的定义。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Google Scholar、clinicalTrials.gov和MEDLINE(1982—2018年),纳入29项研究(22项回顾性、7项前瞻性),共7001例胎盘植入谱系病例、5,719,992次分娩。
主要发现
- 患病率范围为0.01-1.1%,总体合并患病率为0.17%(95%CI 0.14-0.19)。
- 仅10项研究提供详细组织病理学数据;粘连型与植入型分级合并患病率分别为每1000次分娩0.5(95%CI 0.3-0.36)和0.3(95%CI 0.2-0.4)。
- 围产期子宫切除合并发生率为52.2%(95%CI 38.3-66.4;I²=99.8%),需输血出血为46.9%(95%CI 34-59.9;I²=98.8%)。
- 孕产妇死亡合并估计为0.05%(95%CI 0.06-0.69;I²=73%)。
- 所有参数在研究间均存在大量异质性;因研究间在分娩时诊断临床标准、组织病理学确诊及粘连型与植入型鉴别诊断方面方法学不一致,进一步量化受限。
关键数值与推荐
- 主要结局为胎盘植入谱系患病率及出生时临床诊断数据,病理学标准用于确诊。
- 次要结局包括需输血病例、围产期子宫切除发生率及孕产妇死亡率。
- 异质性采用Cochran Q检验和I²统计量分析。
临床怎么用
- 原文未据此给出推荐。
局限性
- 所有参数在研究间均存在大量异质性。
- 因研究间在分娩时诊断临床标准、组织病理学确诊及粘连型与植入型鉴别诊断方面方法学不一致,进一步量化受限。
- 仅10项研究提供详细组织病理学数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE DATA: The objective of this study was to evaluate the prevalence of placenta accreta spectrum in general population studies and the main maternal outcomes at delivery. STUDY: We searched PubMed, Google Scholar, clinicalTrials.gov, and MEDLINE between 1982 and 2018. Articles that provided data on the number of cases of placenta accreta spectrum per pregnancies, births, or deliveries in a defined population were used. STUDY APPRAISAL AND SYNTHESIS METHODS: Study characteristics were evaluated by 2 independent reviewers who used a predesigned protocol. Primary outcomes were the prevalence of placenta accreta spectrum and clinical diagnostic data at birth; the pathologic criteria were used to confirm the diagnosis. Secondary outcomes included cases that required transfusion, incidence of peripartum hysterectomy, and maternal mortality rates. Heterogeneity between studies was analyzed with the Cochran's Q-test and the I2 statistics. RESULTS: Of the 98 full-text studies that were identified, 29 articles met the defined criteria and included 22 retrospective and 7 prospective studies comprising 7001 cases of placenta accreta spectrum of 5,719,992 births. Prevalence rates ranged from 0.01-1.1% with an overall pooled prevalence of 0.17% (95% confidence interval, 0.14-0.19). Only 10 studies provided detailed histopathologic data. The pool prevalence for the adherent vs the invasive grades was 0.5 (95% confidence interval, 0.3-0.36) and 0.3 (95% confidence interval, 0.2-0.4) per 1000 births, respectively. The pooled incidence for peripartum hysterectomy was 52.2% (95% confidence interval, 38.3-66.4; I2=99.8%) and 46.9% (95 % confidence interval, 34-59.9; I2=98.8%) for hemorrhage that required transfusion. The pooled estimate of maternal death was 0.05% (95% confidence interval, 0.06-0.69; I2=73%). We found large amounts of heterogeneity between studies for all parameters and further quantification was limited because of methodologic inconsistencies between studies with regards to clinical criteria that were used for the diagnosis of the condition at birth and the histopathologic confirmation of the diagnosis and differential diagnosis between adherent and invasive accreta placentation. CONCLUSION: This meta-analysis indicated wide variation between studies for the prevalence rate of placenta accreta spectrum and for the different grades of accreta placentation that highlighted the need for consistency in definitions that are used to describe placenta accreta spectrum at birth and in the reporting of this increasing common obstetric complication.
引用
- Jauniaux E, Bunce C, Grønbeck L, et al. Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis. Am J Obstet Gynecol. 2019. PMID: 30716286. doi:10.1016/j.ajog.2019.01.233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。